Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review.

Gallo D, Mortara L, Gariboldi MB, Cattaneo SAM, Rosetti S, Gentile L, Noonan DM, Premoli P, Cusini C, Tanda ML, Bartalena L, Piantanida E.

J Endocrinol Invest. 2019 Oct 4. doi: 10.1007/s40618-019-01123-5. [Epub ahead of print] Review.

PMID:
31584143
2.

Serum miR-223: A Validated Biomarker for Detection of Early-Stage Non-Small Cell Lung Cancer.

D'Antona P, Cattoni M, Dominioni L, Poli A, Moretti F, Cinquetti R, Gini E, Daffrè E, Noonan DM, Imperatori A, Rotolo N, Campomenosi P.

Cancer Epidemiol Biomarkers Prev. 2019 Sep 5. doi: 10.1158/1055-9965.EPI-19-0626. [Epub ahead of print]

PMID:
31488416
3.

Microalgal Derivatives as Potential Nutraceutical and Food Supplements for Human Health: A Focus on Cancer Prevention and Interception.

Galasso C, Gentile A, Orefice I, Ianora A, Bruno A, Noonan DM, Sansone C, Albini A, Brunet C.

Nutrients. 2019 May 29;11(6). pii: E1226. doi: 10.3390/nu11061226. Review.

4.

Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.

Bruno A, Mortara L, Baci D, Noonan DM, Albini A.

Front Immunol. 2019 Apr 18;10:771. doi: 10.3389/fimmu.2019.00771. eCollection 2019. Review.

5.

Downregulation of Pro-Inflammatory and Pro-Angiogenic Pathways in Prostate Cancer Cells by a Polyphenol-Rich Extract from Olive Mill Wastewater.

Baci D, Gallazzi M, Cascini C, Tramacere M, De Stefano D, Bruno A, Noonan DM, Albini A.

Int J Mol Sci. 2019 Jan 14;20(2). pii: E307. doi: 10.3390/ijms20020307.

6.

The human RNASET2 protein affects the polarization pattern of human macrophages in vitro.

Scaldaferri D, Bosi A, Fabbri M, Pedrini E, Inforzato A, Valli R, Frattini A, De Vito A, Noonan DM, Taramelli R, Mortara L, Acquati F.

Immunol Lett. 2018 Nov;203:102-111. doi: 10.1016/j.imlet.2018.09.005. Epub 2018 Sep 12.

PMID:
30218741
7.

Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells.

Mortara L, Gariboldi MB, Bosi A, Bregni M, Pinotti G, Guasti L, Squizzato A, Noonan DM, Monti E, Campiotti L.

Target Oncol. 2018 Oct;13(5):657-665. doi: 10.1007/s11523-018-0586-x.

PMID:
30090970
8.

Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer.

Bruno A, Bassani B, D'Urso DG, Pitaku I, Cassinotti E, Pelosi G, Boni L, Dominioni L, Noonan DM, Mortara L, Albini A.

FASEB J. 2018 Oct;32(10):5365-5377. doi: 10.1096/fj.201701103R. Epub 2018 May 15.

PMID:
29763380
9.

Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization.

Bosi A, Zanellato S, Bassani B, Albini A, Musco A, Cattoni M, Desio M, Nardecchia E, D'Urso DG, Imperatori A, Dominioni L, Noonan DM, Mortara L, Bruno A.

J Immunol Res. 2018 Mar 29;2018:2438598. doi: 10.1155/2018/2438598. eCollection 2018.

10.

Acetyl-l-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways.

Baci D, Bruno A, Bassani B, Tramacere M, Mortara L, Albini A, Noonan DM.

Cancer Lett. 2018 Aug 10;429:100-116. doi: 10.1016/j.canlet.2018.04.018. Epub 2018 Apr 18.

11.

Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.

Albini A, Bruno A, Noonan DM, Mortara L.

Front Immunol. 2018 Apr 5;9:527. doi: 10.3389/fimmu.2018.00527. eCollection 2018. Review.

12.

Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach.

Albini A, Bruno A, Bassani B, D'Ambrosio G, Pelosi G, Consonni P, Castellani L, Conti M, Cristoni S, Noonan DM.

Front Endocrinol (Lausanne). 2018 Apr 5;9:110. doi: 10.3389/fendo.2018.00110. eCollection 2018.

13.

Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer.

Moretti F, D'Antona P, Finardi E, Barbetta M, Dominioni L, Poli A, Gini E, Noonan DM, Imperatori A, Rotolo N, Cattoni M, Campomenosi P.

Oncotarget. 2017 Oct 11;8(55):94980-94996. doi: 10.18632/oncotarget.21739. eCollection 2017 Nov 7. Review.

14.

Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment.

D'Uva G, Baci D, Albini A, Noonan DM.

Cancer Treat Rev. 2018 Feb;63:1-18. doi: 10.1016/j.ctrv.2017.10.013. Epub 2017 Nov 11. Review.

PMID:
29197745
15.

Nutraceuticals and "Repurposed" Drugs of Phytochemical Origin in Prevention and Interception of Chronic Degenerative Diseases and Cancer.

Albini A, Bassani B, Baci D, Dallaglio K, Gallazzi M, Corradino P, Bruno A, Noonan DM.

Curr Med Chem. 2019;26(6):973-987. doi: 10.2174/0929867324666170920144130. Review.

PMID:
28933290
16.

Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues.

Nuti E, Bassani B, Camodeca C, Rosalia L, Cantelmo A, Gallo C, Baci D, Bruno A, Orlandini E, Nencetti S, Noonan DM, Albini A, Rossello A.

Eur J Med Chem. 2017 Sep 29;138:890-899. doi: 10.1016/j.ejmech.2017.07.024. Epub 2017 Jul 17.

PMID:
28750311
17.

Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours?

Mortara L, Benest AV, Bates DO, Noonan DM.

Curr Opin Pharmacol. 2017 Aug;35:66-74. doi: 10.1016/j.coph.2017.05.009. Epub 2017 Jun 14. Review.

PMID:
28623714
18.

SANIST: optimization of a technology for compound identification based on the European Union directive with applications in forensic, pharmaceutical and food analyses.

Cristoni S, Dusi G, Brambilla P, Albini A, Conti M, Brambilla M, Bruno A, Di Gaudio F, Ferlin L, Tazzari V, Mengozzi S, Barera S, Sialer C, Trenti T, Cantu M, Rossi Bernardi L, Noonan DM.

J Mass Spectrom. 2017 Jan;52(1):16-21. doi: 10.1002/jms.3895.

PMID:
27776380
19.

Systemic distribution of single-walled carbon nanotubes in a novel model: alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo.

Principi E, Girardello R, Bruno A, Manni I, Gini E, Pagani A, Grimaldi A, Ivaldi F, Congiu T, De Stefano D, Piaggio G, de Eguileor M, Noonan DM, Albini A.

Int J Nanomedicine. 2016 Sep 1;11:4299-316. doi: 10.2147/IJN.S109950. eCollection 2016.

20.

A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer.

Campomenosi P, Gini E, Noonan DM, Poli A, D'Antona P, Rotolo N, Dominioni L, Imperatori A.

BMC Biotechnol. 2016 Aug 18;16(1):60. doi: 10.1186/s12896-016-0292-7.

21.

Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation.

Gallo C, Dallaglio K, Bassani B, Rossi T, Rossello A, Noonan DM, D'Uva G, Bruno A, Albini A.

Oncotarget. 2016 Sep 13;7(37):59917-59931. doi: 10.18632/oncotarget.10990.

22.

Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.

Bassani B, Bartolini D, Pagani A, Principi E, Zollo M, Noonan DM, Albini A, Bruno A.

PLoS One. 2016 Jul 1;11(7):e0154111. doi: 10.1371/journal.pone.0154111. eCollection 2016.

23.

Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.

Storti P, Marchica V, Airoldi I, Donofrio G, Fiorini E, Ferri V, Guasco D, Todoerti K, Silbermann R, Anderson JL, Zhao W, Agnelli L, Bolzoni M, Martella E, Mancini C, Campanini N, Noonan DM, Petronini PG, Neri A, Aversa F, Roodman GD, Giuliani N.

Leukemia. 2016 Dec;30(12):2351-2363. doi: 10.1038/leu.2016.137. Epub 2016 May 20.

PMID:
27311934
24.

Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells.

Talarico G, Orecchioni S, Dallaglio K, Reggiani F, Mancuso P, Calleri A, Gregato G, Labanca V, Rossi T, Noonan DM, Albini A, Bertolini F.

Sci Rep. 2016 Jan 5;6:18673. doi: 10.1038/srep18673.

25.

Biomarkers of cancer angioprevention for clinical studies.

Albini A, Bertolini F, Bassani B, Bruno A, Gallo C, Caraffi SG, Maramotti S, Noonan DM.

Ecancermedicalscience. 2015 Nov 24;9:600. doi: 10.3332/ecancer.2015.600. eCollection 2015. Review.

26.

NET amyloidogenic backbone in human activated neutrophils.

Pulze L, Bassani B, Gini E, D'Antona P, Grimaldi A, Luini A, Marino F, Noonan DM, Tettamanti G, Valvassori R, de Eguileor M.

Clin Exp Immunol. 2016 Mar;183(3):469-79. doi: 10.1111/cei.12730. Epub 2015 Dec 8.

27.

Environmental impact of multi-wall carbon nanotubes in a novel model of exposure: systemic distribution, macrophage accumulation, and amyloid deposition.

Albini A, Pagani A, Pulze L, Bruno A, Principi E, Congiu T, Gini E, Grimaldi A, Bassani B, De Flora S, de Eguileor M, Noonan DM.

Int J Nanomedicine. 2015 Sep 29;10:6133-45. doi: 10.2147/IJN.S85275. eCollection 2015.

28.

Transgenic mice overexpressing arginase 1 in monocytic cell lineage are affected by lympho-myeloproliferative disorders and disseminated intravascular coagulation.

Astigiano S, Morini M, Damonte P, Fraternali Orcioni G, Cassanello M, Puglisi A, Noonan DM, Bronte V, Barbieri O.

Carcinogenesis. 2015 Nov;36(11):1354-62. doi: 10.1093/carcin/bgv129. Epub 2015 Sep 10.

PMID:
26363032
29.

SANIST: a rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers.

Albini A, Briga D, Conti M, Bruno A, Farioli D, Canali S, Sogno I, D'Ambrosio G, Consonni P, Noonan DM.

Rapid Commun Mass Spectrom. 2015 Oct 15;29(19):1703-10. doi: 10.1002/rcm.7270.

30.

Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.

Lococo F, Paci M, Rapicetta C, Rossi T, Sancisi V, Braglia L, Cavuto S, Bisagni A, Bongarzone I, Noonan DM, Albini A, Maramotti S.

Int J Mol Sci. 2015 Aug 19;16(8):19612-30. doi: 10.3390/ijms160819612.

31.

Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity.

Albini A, Bruno A, Gallo C, Pajardi G, Noonan DM, Dallaglio K.

Connect Tissue Res. 2015;56(5):414-25. doi: 10.3109/03008207.2015.1066780. Epub 2015 Aug 20. Review.

32.

Strategies to Prevent "Bad Luck" in Cancer.

Albini A, Cavuto S, Apolone G, Noonan DM.

J Natl Cancer Inst. 2015 Aug 4;107(10). pii: djv213. doi: 10.1093/jnci/djv213. Print 2015 Oct.

33.

Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes.

Focaccetti C, Bruno A, Magnani E, Bartolini D, Principi E, Dallaglio K, Bucci EO, Finzi G, Sessa F, Noonan DM, Albini A.

PLoS One. 2015 Feb 11;10(2):e0115686. doi: 10.1371/journal.pone.0115686. eCollection 2015.

34.

Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress.

Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F.

Neoplasia. 2014 Sep;16(9):710-22. doi: 10.1016/j.neo.2014.07.012.

35.

The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.

Orecchioni S, Reggiani F, Talarico G, Mancuso P, Calleri A, Gregato G, Labanca V, Noonan DM, Dallaglio K, Albini A, Bertolini F.

Int J Cancer. 2015 Mar 15;136(6):E534-44. doi: 10.1002/ijc.29193. Epub 2014 Sep 18.

36.

A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.

Bruno A, Ferlazzo G, Albini A, Noonan DM.

J Natl Cancer Inst. 2014 Sep 1;106(8):dju200. doi: 10.1093/jnci/dju200. Print 2014 Aug. Review.

37.

Orchestration of angiogenesis by immune cells.

Bruno A, Pagani A, Pulze L, Albini A, Dallaglio K, Noonan DM, Mortara L.

Front Oncol. 2014 Jul 2;4:131. doi: 10.3389/fonc.2014.00131. eCollection 2014. Review.

38.

miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2.

Kronski E, Fiori ME, Barbieri O, Astigiano S, Mirisola V, Killian PH, Bruno A, Pagani A, Rovera F, Pfeffer U, Sommerhoff CP, Noonan DM, Nerlich AG, Fontana L, Bachmeier BE.

Mol Oncol. 2014 May;8(3):581-95. doi: 10.1016/j.molonc.2014.01.005. Epub 2014 Jan 16.

39.

Paradoxic effects of metformin on endothelial cells and angiogenesis.

Dallaglio K, Bruno A, Cantelmo AR, Esposito AI, Ruggiero L, Orecchioni S, Calleri A, Bertolini F, Pfeffer U, Noonan DM, Albini A.

Carcinogenesis. 2014 May;35(5):1055-66. doi: 10.1093/carcin/bgu001. Epub 2014 Jan 13.

40.

Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.

Albini A, Rosano C, Angelini G, Amaro A, Esposito AI, Maramotti S, Noonan DM, Pfeffer U.

Curr Med Chem. 2014;21(9):1129-45.

41.

Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and prevention.

Bruno A, Pagani A, Magnani E, Rossi T, Noonan DM, Cantelmo AR, Albini A.

Cancer Treat Res. 2014;159:401-26. doi: 10.1007/978-3-642-38007-5_23. Review.

PMID:
24114493
42.

Endocrine disruptor agent nonyl phenol exerts an estrogen-like transcriptional activity on estrogen receptor positive breast cancer cells.

Amaro AA, Esposito AI, Mirisola V, Mehilli A, Rosano C, Noonan DM, Albini A, Pfeffer U, Angelini G.

Curr Med Chem. 2014;21(5):630-40.

PMID:
23862621
43.

The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer.

Bruno A, Focaccetti C, Pagani A, Imperatori AS, Spagnoletti M, Rotolo N, Cantelmo AR, Franzi F, Capella C, Ferlazzo G, Mortara L, Albini A, Noonan DM.

Neoplasia. 2013 Feb;15(2):133-42.

44.

Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology.

Albini A, Donatelli F, Focaccetti C, D'Elios MM, Noonan DM.

Intern Emerg Med. 2012 Oct;7(5):399-401. Epub 2012 Sep 2. No abstract available.

PMID:
22941411
45.

Cancer prevention by targeting angiogenesis.

Albini A, Tosetti F, Li VW, Noonan DM, Li WW.

Nat Rev Clin Oncol. 2012 Sep;9(9):498-509. doi: 10.1038/nrclinonc.2012.120. Epub 2012 Jul 31. Review.

PMID:
22850752
46.

Cannabidiol inhibits angiogenesis by multiple mechanisms.

Solinas M, Massi P, Cantelmo AR, Cattaneo MG, Cammarota R, Bartolini D, Cinquina V, Valenti M, Vicentini LM, Noonan DM, Albini A, Parolaro D.

Br J Pharmacol. 2012 Nov;167(6):1218-31. doi: 10.1111/j.1476-5381.2012.02050.x.

47.

Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry.

Sogno I, Conti M, Consonni P, Noonan DM, Albini A.

Rapid Commun Mass Spectrom. 2012 May 30;26(10):1213-8. doi: 10.1002/rcm.6208.

PMID:
22499197
48.

Angiopoietin2 and tie2: tied to lymphangiogenesis and lung metastasis. New perspectives in antimetastatic antiangiogenic therapy.

Albini A, Noonan DM.

J Natl Cancer Inst. 2012 Mar 21;104(6):429-31. doi: 10.1093/jnci/djs032. Epub 2012 Feb 17. No abstract available.

49.

Cardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors.

Albini A, Cesana E, Donatelli F, Cammarota R, Bucci EO, Baravelli M, Anzà C, Noonan DM.

Future Cardiol. 2011 Sep;7(5):693-704. doi: 10.2217/fca.11.54.

50.

Cytokine loaded biopolymers as a novel strategy to study stem cells during wound-healing processes.

Grimaldi A, Banfi S, Vizioli J, Tettamanti G, Noonan DM, de Eguileor M.

Macromol Biosci. 2011 Aug 11;11(8):1008-19. doi: 10.1002/mabi.201000452. Epub 2011 Mar 11.

PMID:
21400659

Supplemental Content

Loading ...
Support Center